GOG-286B A Randomized Phase I/II Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IV or Recurrent Detrimental Cancer
|Effective start/end date||1/1/17 → 12/31/20|
- GYNECOLOGIC ONCOLOGY GROUP
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.